ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Therapeutics
32.53
+1.57
5.07%
盘后:
32.53
0.0000
0.00%
16:19 EDT
成交量:
10.33万
成交额:
332.26万
市值:
9.16亿
市盈率:
-18.39
高:
32.79
开:
31.27
低:
30.86
收:
30.96
数据加载中...
总览
公司
新闻资讯
公告
Sarepta Therapeutics, Inc.7月3日成交额为4532.62万美元
市场透视
·
昨天
Galectin Therapeutics Inc.7月3日成交额为52.13万美元
市场透视
·
昨天
Cero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元
市场透视
·
昨天
据报Summit与阿斯利康洽谈高达150亿美元合作
格隆汇
·
昨天
C4 Therapeutics, Inc.盘中异动 股价大跌5.26%报1.44美元
市场透视
·
昨天
SUMMIT THERAPEUTICS跌幅扩大一度下跌8.4%。
智通财经
·
07-03
Mersana Therapeutics, Inc.盘中异动 快速上涨5.29%
市场透视
·
07-03
Zevra Therapeutics, Inc.盘中异动 股价大涨5.10%报9.89美元
市场透视
·
07-03
Tango Therapeutics, Inc.盘中异动 股价大涨5.31%
市场透视
·
07-03
Alaunos Therapeutics, Inc.盘中异动 早盘急速跳水6.13%
市场透视
·
07-03
Xortx Therapeutics Inc.股价重挫15.70% 市值跌50.13万美元
市场透视
·
07-03
阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD
动脉网
·
07-03
Windtree Therapeutics, Inc.7月2日成交额为6091.30万美元
市场透视
·
07-03
Vyne Therapeutics Inc.7月2日成交额为416.95万美元
市场透视
·
07-03
Sage Therapeutics, Inc.7月2日成交额为1350.52万美元
市场透视
·
07-03
Neumora Therapeutics, Inc.7月2日成交额为91.08万美元
市场透视
·
07-03
Kazia Therapeutics Limited7月2日成交额为7.59万美元
市场透视
·
07-03
Galectin Therapeutics Inc.7月2日成交额为58.90万美元
市场透视
·
07-03
Bicycle Therapeutics Plc盘中异动 早盘股价大涨5.12%报7.39美元
市场透视
·
07-02
Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元
市场透视
·
07-02
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/LENZ/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":32.53,"timestamp":1751562000000,"preClose":30.96,"halted":0,"volume":103266,"hourTrading":{"tag":"盘后","latestPrice":32.53,"preClose":32.53,"latestTime":"16:19 EDT","volume":305,"amount":9921.92,"timestamp":1751573992515},"delay":0,"floatShares":12338525,"shares":28146154,"eps":-1.769251,"marketStatus":"美国独立日休市","change":1.57,"latestTime":"07-03 13:00:00 EDT","open":31.27,"high":32.785,"low":30.86,"amount":3322618.6268,"amplitude":0.062177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":30.96,"postHourTrading":{"tag":"盘后","latestPrice":32.53,"preClose":32.53,"latestTime":"16:19 EDT","volume":305,"amount":9921.92,"timestamp":1751573992515},"volumeRatio":0.42037226896837965,"impliedVol":0.6563,"impliedVolPercentile":0.7627},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":12338525,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.42037226896837965,"shares":28146154,"dividePrice":0,"high":32.785,"amplitude":0.062177,"preClose":30.96,"low":30.86,"week52Low":16.535,"pbRate":"4.77","week52High":38.93,"institutionHeld":0,"latestPrice":32.53,"eps":-1.769251,"divideRate":0,"volume":103266,"delay":0,"ttmEps":-1.769251,"open":31.27,"prevYearClose":28.87,"prevWeekClose":30.18,"prevMonthClose":29.31,"prevQuarterClose":29.31,"fiveDayClose":30.11,"twentyDayClose":29.19,"sixtyDayClose":19.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2548354385","title":"Sarepta Therapeutics, Inc.7月3日成交额为4532.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548354385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548354385?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 14:05","pubTimestamp":1751609132,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Sarepta Therapeutics, Inc.成交额为4532.62万美元,成交额较昨日减少45.97%,当日成交量为248.44万股。Sarepta Therapeutics, Inc.于2025年7月3日涨0.25%,报18.24美元,该股过去5个交易日涨5.86%,年初至今跌85.0%,过去60日跌65.19%。Sarepta的战略包括专有的RNA靶向技术平台,用于开发新型药物产品,以治疗广泛的疾病并解决关键的未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704140542a4cec9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704140542a4cec9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","BK4539","IE00B2B36J28.USD","SRPT","BK4585","IE0009355771.USD","BK4007","LENZ","BK4139","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2548337271","title":"Galectin Therapeutics Inc.7月3日成交额为52.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548337271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548337271?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 10:10","pubTimestamp":1751595046,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Galectin Therapeutics Inc.成交额为52.13万美元,成交额较昨日减少11.50%,当日成交量为23.95万股。Galectin Therapeutics Inc.于2025年7月3日涨0.46%,报2.18美元,该股过去5个交易日跌7.23%,年初至今涨68.99%,过去60日涨63.91%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-03|52.13万|-11.50%|23.95万|#|2025-07-02|58.90万|-39.74%|27.20万|#|2025-07-01|97.74万|-5.38%|44.70万|#|2025-06-30|103.30万|-77.52%|45.71万|#|2025-06-27|459.49万|279.56%|194.67万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ,在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704101049a4ce68ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GALT","BK4539","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2548061334","title":"Cero Therapeutics Holdings, Inc.7月3日成交额为53.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548061334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548061334?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 09:29","pubTimestamp":1751592578,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,Cero Therapeutics Holdings, Inc.成交额为53.02万美元,成交额较昨日减少38.27%,当日成交量为5.68万股。Cero Therapeutics Holdings, Inc.于2025年7月3日跌2.11%,报9.26美元,该股过去5个交易日跌13.3%,年初至今跌92.28%,过去60日跌34.79%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-03|53.02万|-38.27%|5.68万|#|2025-07-02|85.88万|22.72%|9.09万|#|2025-07-01|69.98万|-47.04%|7.50万|#|2025-06-30|132.14万|-46.12%|13.55万|#|2025-06-27|245.26万|-13.78%|24.72万|CERo Therapeutics Holdings Inc 是一家创新的免疫治疗公司,致力于开发用于治疗癌症的下一代工程T细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704092940a72daa44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","CERO"],"gpt_icon":0},{"id":"2548331612","title":"据报Summit与阿斯利康洽谈高达150亿美元合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2548331612","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548331612?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 09:15","pubTimestamp":1751591743,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AZN","LU0320765992.SGD","LU2462157665.USD","LU2417539215.USD","LU2456880835.USD","BK4585","BK4588","LU0109394709.USD","LU1829250122.USD","BK4007","BK4139","LENZ","BK4568","BK4539","LU2236285917.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2548389313","title":"C4 Therapeutics, Inc.盘中异动 股价大跌5.26%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548389313","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548389313?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 00:09","pubTimestamp":1751558959,"startTime":"0","endTime":"0","summary":"北京时间2025年07月04日00时09分,C4 Therapeutics, Inc.股票出现波动,股价快速跳水5.26%。C4 Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。C4 Therapeutics, Inc.公司简介:C4 Therapeutics Inc 是一家临床阶段的生物制药公司,致力于实现靶向蛋白质降解科学的承诺,创造新一代药物,改变患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040009199798cdd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507040009199798cdd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","CCCC"],"gpt_icon":0},{"id":"2548829383","title":"SUMMIT THERAPEUTICS跌幅扩大一度下跌8.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548829383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548829383?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 22:35","pubTimestamp":1751553319,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2548388751","title":"Mersana Therapeutics, Inc.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548388751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548388751?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 22:28","pubTimestamp":1751552939,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时28分,Mersana Therapeutics, Inc.股票出现波动,股价大幅上涨5.29%。Mersana Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Mersana Therapeutics, Inc.公司简介:梅莎娜制药有限公司是一家临床阶段的生物制药公司,专注于开发抗体-药物偶联物 ,为需求未得到满足的癌症患者提供具有临床意义的益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032228599798b84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032228599798b84e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","MRSN","LENZ","BK4007","BK4563","BK4139"],"gpt_icon":0},{"id":"2548638863","title":"Zevra Therapeutics, Inc.盘中异动 股价大涨5.10%报9.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548638863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548638863?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 22:10","pubTimestamp":1751551817,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时10分,Zevra Therapeutics, Inc.股票出现波动,股价急速拉升5.10%。Zevra Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Zevra Therapeutics, Inc.公司简介:Zevra Therapeutics Inc 是一家专注于罕见病的公司,将科学、数据和患者需求相结合,为那些治疗选择有限或根本没有治疗选择的疾病创造变革性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703221017a72cea9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703221017a72cea9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","ZVRA"],"gpt_icon":0},{"id":"2548388528","title":"Tango Therapeutics, Inc.盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548388528","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548388528?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 22:05","pubTimestamp":1751551501,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日22时05分,Tango Therapeutics, Inc.股票出现波动,股价快速拉升5.31%。截至发稿,该股报5.95美元/股,成交量10.1883万股,换手率0.09%,振幅4.21%。Tango Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Theratechnologies Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大,Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Oragenics Inc.较为活跃,换手率分别为1871.45%、674.23%、179.61%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Clearmind Medicine Inc.,振幅分别为63.64%、49.41%、33.22%。Tango Therapeutics, Inc.公司简介:Tango Therapeutics Inc 是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703220501a4cd8a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703220501a4cd8a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","TNGX","BK4007","LENZ"],"gpt_icon":0},{"id":"2548800697","title":"Alaunos Therapeutics, Inc.盘中异动 早盘急速跳水6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548800697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548800697?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 21:46","pubTimestamp":1751550365,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时46分,Alaunos Therapeutics, Inc.股票出现异动,股价快速下跌6.13%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。其相关个股中,Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Theratechnologies Inc.涨幅较大,Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为1774.63%、898.69%、631.46%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为54.55%、38.11%、36.41%。Alaunos Therapeutics, Inc.公司简介:Alaunos Therapeutics Inc是一家临床阶段的细胞免疫肿瘤学公司,致力于通过采用TCR-T细胞疗法治疗实体肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214605a4cd82b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703214605a4cd82b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","TCRT","LENZ","BK4539"],"gpt_icon":0},{"id":"2548807465","title":"Xortx Therapeutics Inc.股价重挫15.70% 市值跌50.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548807465?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 21:31","pubTimestamp":1751549488,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分,Xortx Therapeutics Inc.股票出现异动,股价急速下挫15.70%。截至发稿,该股报0.843美元/股,成交量316.985万股,换手率83.68%,振幅0.20%。Xortx Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.10%。其相关个股中,Lixte Biotechnology Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Windtree Therapeutics, Inc.、Clearmind Medicine Inc.、Lixte Biotechnology Holdings, Inc.较为活跃,换手率分别为1677.81%、514.10%、437.39%,振幅较大的相关个股有Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Lixte Biotechnology Holdings, Inc.、Clearmind Medicine Inc.,振幅分别为27.18%、26.73%、12.17%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213128a72cdadb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","XRTX","BK4539","BK4007"],"gpt_icon":0},{"id":"2548875812","title":"阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2548875812","media":"动脉网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548875812?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 15:36","pubTimestamp":1751528160,"startTime":"0","endTime":"0","summary":"Ashvattha Therapeutics Shares Positive Interim Phase 2 Results for SubQ MGB in DME, AMD阿什瓦塔治疗公司分享了SubQ MGB在DME、AMD中的积极中期2期结果July 03, 20252025年7月3日Ashvattha Therapeutics has announced promising interim results from its ongoing phase 2 study of subcutaneous migaldendranib for the treatment of diabetic macular edema and wet age-related macular degeneration . The findings were presented at the MaculArt Meeting, held from June 29 to July 1, 2025, in Paris.Ashvattha Therapeutics 宣布了其正在进行的皮下注射米加仑丹尼治疗糖尿病性黄斑水肿和湿性年龄相关性黄斑变性的 2 期研究的积极中期结果。这些研究成果于 2025 年 6 月 29 日至 7 月 1 日在巴黎举行的 MaculArt 会议上公布。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031540199534f13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507031540199534f13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B5949003.HKD","LU1242518857.USD","BK4534","BK4588","BK4605","LU1064131342.USD","BK4543","LU0127658192.USD","AMD","IE0004445239.USD","LU0719512351.SGD","LU1852331112.SGD","LU1803068979.SGD","LU0823421416.USD","BK4573","LU2458330169.SGD","BK4532","LU2458330243.SGD","LU1988902786.USD","BK4007","LU1951198990.SGD","BK4612","LU1880398554.USD","BK4539","GFS","LU0198837287.USD","LU0823421333.USD","LU1923623000.USD","LU1303367103.USD","LU2264538146.SGD","LU1242518931.SGD","LU2360106780.USD","IE00BMPRXR70.SGD","IE00BMPRXN33.USD","LU0979878070.USD","LENZ","BK4575","LU2250418816.HKD","BK4614","BK4585","LU1316542783.SGD","BK4554","LU0390134368.USD","BK4529","BK4139","LU1880398471.USD","LU0823434740.USD","LU1989764664.SGD","LU0082616367.USD","LU0056508442.USD"],"gpt_icon":1},{"id":"2548935879","title":"Windtree Therapeutics, Inc.7月2日成交额为6091.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548935879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548935879?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 15:35","pubTimestamp":1751528155,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Windtree Therapeutics, Inc.成交额为6091.30万美元,成交额较昨日增加7308.03%,当日成交量为7867.76万股。Windtree Therapeutics, Inc.于2025年7月2日涨40.0%,报0.77美元,该股过去5个交易日涨108.11%,年初至今跌95.59%,过去60日跌40.77%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|6091.30万|7308.03%|7867.76万|#|2025-07-01|82.23万|-33.45%|159.56万|#|2025-06-30|123.56万|113.55%|255.13万|#|2025-06-27|57.86万|-81.37%|132.36万|#|2025-06-26|310.65万|612.39%|701.43万|Windtree Therapeutics Inc 是一家生物技术公司,专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703161153a4ccda98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703161153a4ccda98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WINTW","BK4007","BK4539","LENZ","BK4139","WINT"],"gpt_icon":0},{"id":"2548876533","title":"Vyne Therapeutics Inc.7月2日成交额为416.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548876533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548876533?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 15:23","pubTimestamp":1751527437,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Vyne Therapeutics Inc.成交额为416.95万美元,成交额较昨日增加21.28%,当日成交量为263.88万股。Vyne Therapeutics Inc.于2025年7月2日跌14.69%,报1.51美元,该股过去5个交易日涨10.22%,年初至今跌54.93%,过去60日跌3.21%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|416.95万|21.28%|263.88万|#|2025-07-01|343.79万|103.27%|188.80万|#|2025-06-30|169.13万|-10.91%|106.36万|#|2025-06-27|189.83万|-76.67%|123.81万|#|2025-06-26|813.80万|-22.31%|497.75万|VYNE Therapeutics Inc 是一家生物制药公司,专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703153524a72c2771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","BK4139","VYNE"],"gpt_icon":0},{"id":"2548824468","title":"Sage Therapeutics, Inc.7月2日成交额为1350.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548824468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548824468?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 13:39","pubTimestamp":1751521197,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Sage Therapeutics, Inc.成交额为1350.52万美元,成交额较昨日增加73.01%,当日成交量为148.28万股。Sage Therapeutics, Inc.于2025年7月2日涨0.0%,报9.08美元,该股过去5个交易日跌1.84%,年初至今涨67.22%,过去60日涨32.36%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|1350.52万|73.01%|148.28万|#|2025-07-01|780.60万|-68.53%|85.87万|#|2025-06-30|2480.35万|-42.16%|272.33万|#|2025-06-27|4288.02万|399.47%|467.55万|#|2025-06-26|858.52万|-11.48%|93.00万|Sage Therapeutics Inc 是一家专注于脑健康药物的临床阶段生物制药公司。该公司还有其他药物正在研发中,例如 SAGE-324、Dalzanemdor 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134008a72bf8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703134008a72bf8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SAGE","LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2548829651","title":"Neumora Therapeutics, Inc.7月2日成交额为91.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548829651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548829651?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 12:20","pubTimestamp":1751516425,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Neumora Therapeutics, Inc.成交额为91.08万美元,成交额较昨日增加20.11%,当日成交量为113.66万股。Neumora Therapeutics, Inc.于2025年7月2日跌1.77%,报0.782美元,该股过去5个交易日跌3.19%,年初至今跌92.62%,过去60日涨6.13%。该公司已扩大其治疗产品线,目前包括七个临床和临床前神经科学项目,旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NMRA","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2548825301","title":"Kazia Therapeutics Limited7月2日成交额为7.59万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548825301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548825301?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 11:12","pubTimestamp":1751512326,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Kazia Therapeutics Limited成交额为7.59万美元,成交额较昨日减少62.12%,当日成交量为1.17万股。Kazia Therapeutics Limited于2025年7月2日跌0.75%,报6.58美元,该股过去5个交易日跌0.15%,年初至今跌25.65%,过去60日涨85.09%。该集团正在开发一种潜在的治疗胶质母细胞瘤的药物paxalisib;用于治疗卵巢癌的Cantrixil;和一些其他药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703111213a72bc0b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KZIA","LENZ","NVGNF","BK4539","BK4139"],"gpt_icon":0},{"id":"2548283918","title":"Galectin Therapeutics Inc.7月2日成交额为58.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548283918","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548283918?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 10:09","pubTimestamp":1751508578,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,Galectin Therapeutics Inc.成交额为58.90万美元,成交额较昨日减少39.74%,当日成交量为27.20万股。Galectin Therapeutics Inc.于2025年7月2日跌2.25%,报2.17美元,该股过去5个交易日跌13.55%,年初至今涨68.22%,过去60日涨64.39%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-07-02|58.90万|-39.74%|27.20万|#|2025-07-01|97.74万|-5.38%|44.70万|#|2025-06-30|103.30万|-77.52%|45.71万|#|2025-06-27|459.49万|279.56%|194.67万|#|2025-06-26|121.06万|63.43%|49.96万|Galectin Therapeutics Inc是一家临床阶段生物制药公司。公司的galectin-3 抑制剂是belapectin ,在临床前模型中已被证明可以逆转肝纤维化和肝硬化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703100947a4cc3dae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703100947a4cc3dae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GALT","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2548813293","title":"Bicycle Therapeutics Plc盘中异动 早盘股价大涨5.12%报7.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548813293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548813293?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 22:31","pubTimestamp":1751466669,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时31分,Bicycle Therapeutics Plc股票出现异动,股价急速拉升5.12%。截至发稿,该股报7.39美元/股,成交量23.1809万股,换手率0.33%,振幅6.61%。Bicycle Therapeutics Plc股票所在的生物技术行业中,整体涨幅为0.79%。Bicycle Therapeutics Plc公司简介:Bicycle Therapeutics PLC 是一家临床阶段的生物制药公司,正在开发一种被称为 Bicycles 的新型药物。Bicycles 是合成的短肽,被限制形成两个环以稳定其结构几何形状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222310997976513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222310997976513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BCYC","BK4007","BK4139"],"gpt_icon":0},{"id":"2548818490","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548818490?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 22:06","pubTimestamp":1751465187,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时06分,Lineage Cell Therapeutics, Inc.股票出现波动,股价大幅上涨5.18%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.82%。Lineage Cell Therapeutics, Inc.公司简介:Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司,专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4539","LINE","BK4007","LCTX","LENZ","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"盘前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-07-03","current":-19.178768,"percent":0,"low":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"high":-5.069183,"avg":-11.134961,"sd":3.869622,"marketCap":915594389},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389}],"updateTime":1751623286893}}}